Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef J Fox

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
JAMA Oncology|November 10, 2017
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate CancerJosef J Fox, Somali C Gavane, Estelle Blanc-Autran, et al.
European Urology|February 7, 2012
A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan IndexDavid Ulmert, Reza Kaboteh, Josef J Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2020
First-in-Human Trial of Epichaperome-Targeted PET in Patients with CancerMark P S Dunphy, Christina Pressl, Nagavarakishore Pillarsetty, et al.
JCO Precision Oncology|October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate CancerDavid R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2020
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I StudyKaren A Autio, Christopher A Klebanoff, David Schaer, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
JAMA Oncology|November 10, 2017
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate CancerJosef J Fox, Somali C Gavane, Estelle Blanc-Autran, et al.
European Urology|February 7, 2012
A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan IndexDavid Ulmert, Reza Kaboteh, Josef J Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2020
First-in-Human Trial of Epichaperome-Targeted PET in Patients with CancerMark P S Dunphy, Christina Pressl, Nagavarakishore Pillarsetty, et al.
JCO Precision Oncology|October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate CancerDavid R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2020
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I StudyKaren A Autio, Christopher A Klebanoff, David Schaer, et al.
Pageof 4